These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5446374)

  • 21. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 23. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
    Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of ( 3 H)catecholamines in the brain following the peripheal administration of 3 H-dopa during pre- and postnatal development.
    Kellogg C; Lundborg P
    Brain Res; 1972 Jan; 36(2):333-42. PubMed ID: 5061894
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of L-DOPA analogues in Sidman avoidance performance in mice.
    Thut PD
    Life Sci; 1977 Aug; 21(3):423-31. PubMed ID: 895374
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.
    Lytle LD; Hurko O; Romero JA; Cottman K; Leehey D; Wurtman RJ
    J Neural Transm; 1972; 33(1):63-71. PubMed ID: 4641868
    [No Abstract]   [Full Text] [Related]  

  • 31. Presence of alpha-methyl-DOPA metabolites in heart and brain of guinea pigs treated with alpha-methyl-tyrosine.
    Maître L
    Life Sci; 1965 Dec; 4(23):2249-56. PubMed ID: 5880875
    [No Abstract]   [Full Text] [Related]  

  • 32. Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
    Atkinson M; Hartley D; Lunts LH; Ritchie AC
    J Med Chem; 1974 Feb; 17(2):248-9. PubMed ID: 4809259
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 34. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD; Cattabeni F; Costa E
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical lonization mass spectrometric measurement of alpha-methyldopa and s-dopa metabolites in rat brain regions.
    Freed CR; Weinkam RJ; Melmon KL; Castagnoli N
    Anal Biochem; 1977 Apr; 78(2):319-32. PubMed ID: 851208
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 38. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G; Pletscher A; Burkard WP
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on rheomelanins. I. The formation of rheomelanins in human blood plasma from catecholamines, from L-dopa and from some of their derivatives.
    Hegedus ZL; Altschule MD
    Arch Int Physiol Biochim; 1970 Aug; 78(3):443-59. PubMed ID: 4097994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.